(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMULAÇÃO COMPREENDENDO DAPRODUSTAT

ArquivadaInvention PatentPCT · EP2021066386

Application data

Number

112022024533

Type

Invention Patent

Filing

06/17/2021

Publication

12/27/2022

PCT

EP2021066386

Progress at the INPI

  1. Filing06/17/21
  2. Publication12/27/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/21/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED

GB

See this company's full portfolio

Inventors

J. M. (pessoa física)

US

S. C. (pessoa física)

US

S. C. (pessoa física)

US

Technical data

Priority claims

US

63/041,403 · 06/19/2020

US

63/043,292 · 06/24/2020

Abstract

FORMULAÇÃO COMPREENDENDO DAPRODUSTAT. A presente divulgação refere-se a um comprimido de liberação imediata de daprodustat com resistência à tração satisfatória. Em outros aspectos, usos médicos do comprimido de liberação imediata e regimes de dosagem para usar o comprimido de liberação imediata são divulgados.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

10/21/2025

RPI 2859

Parecer de pré-exame

#6.23

07/08/2025

RPI 2844

Notificação de entrada na fase nacional - PCT

#1.3

12/27/2022

RPI 2712

Alteração de dados cadastrais

#1.1

12/13/2022

RPI 2710

Related

From the same holder

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.